Tocagen (TOCA) Posts Wider Q4 Loss
Tweet
Share
E-mailGet Alerts TOCA Hot Sheet
Join SI Premium – FREE
Tocagen (NASDAQ: TOCA) reported Q4 EPS of ($0.96), $0.28 worse than the analyst estimate of ($0.68).
For earnings history and earnings-related data on Tocagen (TOCA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
